Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy-Reference-Cited by-同舟云学术

Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

Published:2014-01-31 Issue:1 Volume:9 Page:e84940
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

De Re Valli,Caggiari Laura,De Zorzi Mariangela,Talamini Renato,Racanelli Vito,Andrea Mario D’,Buonadonna Angela,Zagonel Vittorina,Cecchin Erika,Innocenti Federico,Toffoli Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference73 articles.

1. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial;J Bennouna;Lancet Oncol,2013

2. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, et al.. (2011) Irinotecan combined with fluorouracil comparedwith fluorouracil alone as first-line treatment formetastatic colorectal cancer: A multicentre randomized trial. Lancet 355,1041–1047.

3. Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody;EJ Lipson;Clin Cancer Res,2013

4. Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, et al.. (2013) Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value. PLoS Medicine 10.

5. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria;JD Wolchok;Clin Cancer Res,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma;PLOS ONE;2023-08-30

2. Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage;Current Molecular Medicine;2023-07-17

3. HLA / MHC and KIR characterization in humans and non‐human primates using Oxford Nanopore Technologies and Pacific Biosciences sequencing platforms;HLA;2023-01-09

4. Contribution of natural killer cells in innate immunity against colorectal cancer;Frontiers in Oncology;2023-01-04

5. Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer;Pharmaceutics;2022-12-07